Diabetes tied to early voluntary retirement from job, finds study
Finland: Type 1 diabetes (T1D) patients, on average, exit the labor force at earlier ages than people with type 2 diabetes (T2D), finds a recent study in the journal Diabetologia. These exits, on average, results in higher lost mean productivity costs and mean lost working years than in those with T2D. Since the complications contribute to an early exit from the labor force regardless of the type of diabetes, efforts should be made to prevent complications and to manage and diagnose diabetes in a timely manner.
Diabetes and its complications are a cause of substantial morbidity that results in lost productivity and early exits from the labor force. Olli Kurkela, Finnish Institute for Health and Welfare, Helsinki, Finland, and colleagues aimed to examine differences in early exits between people with type 1 and 2 diabetes and to assess the role of chronic diabetes complications on early exit. The researchers also estimated the economic burden of lost productivity due to early exits.
The researchers detected people of working age (age 17–64) with diabetes in 1998–2011 in Finland using national registers (Ntype 1 = 45,756, Ntype 2 = 299,931). For the open cohort, data on pensions and deaths, medications, health care usage, and basic demographics were collected from the registers.
The outcome of the study was early exit from the labour force defined as pension other than old age pension beginning before age 65, or death before age 65.
Key findings of the study include:
- The difference in median age at early exit from the labour force between type 1 (54.0) and type 2 (58.3) diabetes groups was 4.3 years.
- The risk of early exit among people with type 1 diabetes increased faster after age 40 compared with people with type 2 diabetes.
- Each of the diabetes complications was associated with an increase in the hazard of early exit regardless of diabetes type compared with people without the complication, with eye-related complications as an exception.
- Diabetes complications partly but not completely explained the difference between diabetes types.
- The mean lost working years was 6.0 years greater in the type 1 diabetes group than in the type 2 diabetes group among people with early exit.
- Mean productivity costs of people with type 1 diabetes and early exit were found to be 1.4-fold greater compared with people with type 2 diabetes.
- The total productivity costs of incidences of early exits in the type 2 diabetes group were notably higher compared with the type 1 group during the time period (€14,400 million, €2800 million).
"We found a marked difference in the patterns of risk of early exit between people with type 1 and type 2 diabetes. The difference was largest close to statutory retirement age," wrote the authors. "On average, exits in the type 1 diabetes group occurred at an earlier age and resulted in higher mean lost working years and mean productivity costs. The potential of prevention, timely diagnosis and management of diabetes is substantial in terms of avoiding reductions in individual well-being and productivity."
Reference:
The study titled, "Association of diabetes type and chronic diabetes complications with early exit from the labour force: register-based study of people with diabetes in Finland," is published in the journal Diabetologia.
DOI: https://link.springer.com/article/10.1007/s00125-020-05363-6
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.